On this page · 5 sections→
Where the EU money came from
Funding by EU programme. Amounts are Crown Bioscience Netherlands BV's own share of each project, not the project's full budget.
- Horizon Europe€1.2M · 4 projects
- Horizon 2020€981k · 5 projects
Projects
9 EU-funded projects, newest first. Crown Bioscience Netherlands BV led 1 of them as coordinator. Each links to the official record.
- dIscOverNETPartner
Developing Immune Strategies to Counter tumor-immune-micrOnVironmEntal Resistance in NeuroEndocrine Tumors.
Horizon Europe · 2027–2030 · Project on CORDIS ↗
€611ktheir share - FOCUS-4RPartner
Fostering Outermost regions Capabilities in Research and Innovation and Upgrading Skills complying with 4R principles
Horizon Europe · 2025–2029 · Project on CORDIS ↗
€96ktheir share - BRECISEPartner
Biomarker Research and Evaluation for Clinical Implementation and Supporting Systems Enhancement
Horizon Europe · 2025–2029 · Project on CORDIS ↗
€481ktheir share - Maxima ButterflyAssociated partner
From Caterpillar to BUTTERFLY: supporting transformation of DCs in a paediatric oncology network
Horizon Europe · 2023–2027 · Project on CORDIS ↗
- DRUGtrainPartner
Drug repurposing and discovery multidisciplinary training network
Horizon 2020 · 2021–2024 · Project on CORDIS ↗
€266ktheir share - TRIM-NETPartner
Training network in drug discovery targeting TRIM Ubiquitin ligases in disease
Horizon 2020 · 2019–2023 · Project on CORDIS ↗
- EDIReXPartner
EurOPDX Distributed Infrastructure for Research on patient-derived cancer Xenografts
Horizon 2020 · 2018–2022 · Project on CORDIS ↗
€255ktheir share - 3DPDCoordinator
PhD position in commercial environment: cancer immunotherapy drug screening in 3D
Horizon 2020 · 2017–2018 · Project on CORDIS ↗
€135ktheir share - TransQSTPartner
Translational quantitative systems toxicology to improve the understanding of the safety of medicines - Sofia: 116030
Horizon 2020 · 2017–2022 · Project on CORDIS ↗
€325ktheir share
Works most with
Organisations that shared the most EU projects with this one. A good starting list for consortium partners.
- Erasmus Universitair Medisch Centrum RotterdamNetherlands · 4 shared projects
- European Molecular Biology LaboratoryGermany · 3 shared projects
- Stichting Het Nederlands Kanker Instituut-Antoni van Leeuwenhoek ZiekenhuisNetherlands · 3 shared projects
- Katholieke Universiteit LeuvenBelgium · 2 shared projects
- Institut National de la Sante et de la Recherche MedicaleFrance · 2 shared projects
- The University of ManchesterUnited Kingdom · 2 shared projects
- Academisch Ziekenhuis LeidenNetherlands · 2 shared projects
- Academisch Ziekenhuis GroningenNetherlands · 2 shared projects
- Institut CurieFrance · 2 shared projects
- Universitaetsklinikum AachenGermany · 2 shared projects
- Janssen Pharmaceutica NVBelgium · 2 shared projects
- Centre National de la Recherche Scientifique CNRSFrance · 1 shared project
- The Chancellor, Masters and Scholars of the University of OxfordUnited Kingdom · 1 shared project
- The Chancellor Masters and Scholars of the University of CambridgeUnited Kingdom · 1 shared project
- Agencia Estatal Consejo Superior de Investigaciones CientificasSpain · 1 shared project
- Universiteit GentBelgium · 1 shared project
Fields it works in
Research fields recorded on its Horizon projects.
- adverse drug reactions
- artificial intelligence
- bladder cancer
- cardiac arrhythmia
- cell biology
- colorectal cancer
- commerce
- drug discovery
- drug safety
- ecosystems
- entrepreneurship
- immunotherapy
- mutation
- neurobiology
Is this your organisation?
Claim it with an EUACC listing (€39 once, reviewed by our editors): add what you build, your team and what you are looking for. We pre-fill it from your EU records. Listed companies reach investors through our newsletter and get matched to new EU calls first.
Claim this profile →Source: CORDIS (Horizon Europe, Horizon 2020, FP7) and the EU Funding & Tenders Portal (other EU programmes), matched by the EU registration number (PIC). Past participation does not mean the organisation is open to new partnerships.
